Epigenetic changes as a common trigger of muscle weakness in congenital myopathies

Human Molecular Genetics

Volumn 24, Issue 16, 2015, Pages 4636-4647

  Rokach, Ori ^a   Sekulic Jablanovic, Marijana ^a   Voermans, Nicol ^b   Wilmshurst, Jo ^c   Pillay, Komala ^c,d   Heytens, Luc ^e   Zhou, Haiyan ^f   Muntoni, Francesco ^f   Gautel, Mathias ^g   Nevo, Yoram ^h   Mitrani Rosenbaum, Stella ^h   Attali, Ruben ^h   Finotti, Alessia ⁱ   Gambari, Roberto ⁱ   Mosca, Barbara ⁱ   Jungbluth, Heinz ^j,k   Zorzato, Francesco ^a,i   Treves, Susan ^a,i  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

ⁱ UNIVERSITY OF FERRARA   (Italy)

^j ST THOMAS HOSPITAL   (United Kingdom)

^k KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; MICRORNA; MICRORNA 1; MICRORNA 124; MICRORNA 126; MICRORNA 133; MICRORNA 22; MICRORNA 221; MICRORNA 486; RYANODINE RECEPTOR 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; HDAC5 PROTEIN, MOUSE; HISTONE DEACETYLASE; RYANODINE RECEPTOR; RYANODINE RECEPTOR 1, MOUSE;

ANIMAL TISSUE; ARTICLE; CONGENITAL MYOPATHY; CONTROLLED STUDY; DNA METHYLATION; ENZYME INDUCTION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MOUSE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE LEVEL; MUSCLE WEAKNESS; MYOPATHY; NEMALINE MYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; GENETIC EPIGENESIS; GENETICS; METABOLISM; MUTATION; PATHOLOGY; THOMSEN DISEASE;

MUS MUSCULUS;

ANIMALS; EPIGENESIS, GENETIC; HISTONE DEACETYLASES; MICE; MUSCLE WEAKNESS; MUTATION; MYOTONIA CONGENITA; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84938523445     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv195     Document Type: Article

References (58)

1. Maggi, L., Scoto, M., Cirak, S., Robb, S.A., Klein, A., Lillis, S., Cullup, T., Feng, L., Manzur, A.Y., Sewry, C.A. et al. (2013) Congenital myopathies-clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul. Disord., 23, 195-205.
2. Zhou, H., Jungbluth, H., Sewry, C.A., Feng, L., Bertini, E., Bushby, K., Straub, V., Roper, H., Rose, M.R., Brockington, M. et al. (2007) Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain, 130, 2024-2036.
3. Wilmhurst, J.M., Lillis, S., Zhou, H., Pillay, K., Henderson, H., Kress, W., Müller, C.R., Ndondo, A., Cloke, V., Cullup, T. et al. (2010) RYR1 mutations are acommon cause of congenital myopathies with central nuclei. Ann. Neurol., 68, 717-726.
4. Clarke, N.F., Waddell, L.B., Cooper, S.T., Perry, M., Smith, R.L., Kornberg, A.J., Muntoni, F., Lillis, S., Straub, V., Bushby, K. et al. (2010) Recessive mutations in RYR1 are a commoncause of Congenital Fiber Type disproportion. Hum. Mutat., 31, E1544-E1550.
5. Franzini-Armstrong, C. and Protasi, F.G. (1997) Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol. Rev., 77, 699-729.
6. Treves, S., Jungbluth, H., Muntoni, F. and Zorzato, F. (2008) Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol., 8, 319-326.
7. Zhou, H., Rokach, O., Feng, L., Munteanu, I., Mamchaoui, K., Wilmshurst, J.M., Sewry, C., Manzur, A.Y., Pillay, K., Mouly, V. et al. (2013) RYR1 deficiency in congenital myopathies disrupts excitation-contraction coupling. Hum. Mutat., 34, 986-996.
8. Attali, R., Aharoni, S., Treves, S., Rokach, O., Becker-Cohen, M., Fellig, Y., Straussberg, R., Do, T., Daana, M., Mitrani-Rosenbaum, S. and Nevo, Y. (2013) Variable myopathic presentation in a single family with novel skeletal RYR1 mutation. PLoS One, 8, e69296. doi:10.1371/journal. pone. 0069296.
9. Emery, A.E. (1991) Population frequencies of inheritedneuromuscular diseases-aworld survey. Neuromuscul. Disord., 1, 19-29.
10. Zhou, H., Yamaguchi, N., Xu, L., Wang, Y., Sewry, C., Jungbluth, H., Zorzato, F., Bertini, E., Muntoni, F., Meissner, G. and Treves, S. (2006) Characterization of recessive RYR1 mutations in core myopathies. Hum. Mol. Genet., 16, 2791-2803.
11. Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L. and Wang, D.Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 38, 228-233.
12. Kim, H.K., Lee, Y.S., Sivaprasad, U., Malhotra, A. and Dutta, A. (2006) Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell. Biol., 174, 677-687.
13. Small, E.M., O'Rourke, J.R., Moresi, V., Sutherland, L.B., McAnally, J., Gerard, R.D., Richardson, J.A. and Olson, E.N. (2010) Regulation of PI3-kinase/Akt signaling by muscle enriched microRNA-486. Proc. Natl Acad. Sci. USA., 107, 4218-4223.
14. Wang, M., Zhao, C., Shi, H., Zhang, B., Zhang, L., Zhang, X., Wang, S., Wu, X., Yang, T., Huang, F. et al. (2014) Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br. J. Cancer., 110, 1199-1210.
15. Sun, X., Wang, Z.M., Song, Y., Tai, X.H., Ji, W.Y. and Gu, H. (2014) MicroRNA-126 modulates the tumor microenvironment by targeting calmodulin-regulated spectrin-associated protein 1 (Camsap1). Int. J. Oncol., 44, 1678-1684.
16. Jungbluth, H., Sewry, C. and Muntoni, F. (2011) Core myopathies. Semin. Pediatr. Neurol., 18, 239-249.
17. Workmann, J.L. and Kingston, R.E. (1998) Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem., 67, 545-579.
18. Lu, J., McKinsey, T.A., Zhang, C.L. and Olson, E.N. (2000) Regulation of skeletal myogenesis by association of the mef2 transcription factor with class II Histone deacetylases. Mol. Cell., 6, 233-244.
19. Zhang, J., Yang, Y., Yang, T., Liu, Y., Li, A., Fu, S., Wu, M., Pan, Z. and Zhou, W. (2010) microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer, 103, 1215-1220.
20. Potthoff, M.J., Arnold, M.A., McAnally, J., Richardson, J.A., Bassel-Duby, R. and Olson, E.N. (2007) Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol. Cell Biol., 27, 8143-8151.
21. Hinits, Y. and Hughes, S.M. (2007) Mef2s are required for thick filament formation in nascent muscle fibres. Development, 134, 2511-2519.
22. Naya, F.J. and Olson, E. (1999) MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol., 11, 683-688.
23. McKinsey, T.A., Zhang, C.L., Lu, J. and Olson, E.N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature, 408, 106-111.
24. Schmoelzl, S., Leeb, T., Brinkmeier, H., Brem, G. and Brenig, B. (1996) Regulation of tissue-specific expression of the skeletal muscle ryanodine receptor gene. J. Biol. Chem., 271, 4763-4769.
25. Liu, N., Williams, A.H., Kim, Y., McAnally, J., Bezprozvannaya, S., Sutherland, L.B., Richardson, J.A., Bassel-Duby, R. and Olson, E.N. (2007) An intragenic MEF2-dependent enhancer directsmuscle-specific expression ofmicroRNAs 1 and 133Mef2 and myomesin. Proc. Natl Acad. Sci. USA, 104, 20844-20849.
26. Zhou, H., Lillis, S., Loy, R.E., Ghassemi, F., Rose, M.R., Norwood, F., Mills, K., Al-Sarraj, S., Lane, R.J., Feng, L. et al. (2010) Multiminicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul. Disord., 20, 166-173.
27. Monnier, N., Marty, I., Faure, J., Castiglioni, C., Desnuelle, C., Sacconi, S., Estournet, B., Ferreiro, A., Romero, N., Laquerriere, A. et al. (2008) Nullmutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenitalmyopathies with cores. Hum. Mutat., 29, 670-678.
28. Bevilacqua, J.A., Monnier, N., Bitoun, M., Eymard, B., Ferreiro, A., Monges, S., Lubieniecki, F., Taratuto, A.L., Laquerrière, A., Claeys, K.G. et al. (2011) Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol. Appl. Neurobiol., 37, 271-284.
29. Bongers, K.S., Fox, D.K., Ebert, S.M., Kunkel, S.D., Dyle, M.C., Bullard, S.A., Dierdorff, J.M. and Adams, C.M. (2013) Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. Am. J. Physiol. Endocrinol. Metab., 98, 4089-4096.
30. Bruneteau, G., Simonet, T., Bauché, S., Mandjee, N., Malfatti, E., Girard, E., Tanguy, M.L., Behin, A., Khiami, F., Sariali, E. et al. (2013) Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain, 136, 2359-2368.
31. Mielcarek, M., Landles, C., Weiss, A., Bradaia, A., Seredenina, T., Inuabasi, L., Osborne, G.F., Wadel, K., Touller, C., Butler, R. et al. (2013) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLOS Biol., 11, e1001717.
32. Cohen, T.J., Waddell, D.S., Barrientos, T., Lu, Z., Feng, G., Cox, G.A., Bodine, S.C. and Yao, T.P. (2007) The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J. Biol. Chem., 282, 33752-33759.
33. Consalvi, S., Saccone, V., Giordani, L., Minetti, G., Mozzetta, C. and Puri, P.L. (2011) Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases. Mol. Med., 17, 457-465.
34. Falkenberg, K.J. and Johnstone, R.W. (2014) Histone deacetylases and their inhibitors in cancers, neurological dieases and immune disorders. Nature Rev. Drug. Discov., 13, 673-691.
35. Wang, Z., Qin, G. and Zhao, T.C. (2014) HDAC4: mechanism of regulation and biological functions. Epigenomics, 6, 139-150.
36. Baylin, S.B., Esteller, M., Rountree, M.R., Bachmanm, K.E., Schuebelm, K. and Herman, J.G. (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet., 10, 687-692.
37. Lu, J., McKinsey, T.A., Nicolm, R.L. and Olson, E.N. (2000) Signal dependent activation of the MEF2 transcription factor by dissociation from histone deacytlases. Proc. Natl Acad. Sci. USA, 97, 4070-4075.
38. Miska, E.A., Karlsson, C., Langley, E., Nielesen, S.J., Pines, J. and Kouzaridesm, T. (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor MEF2 transcription factor. EMBO J., 18, 5099-5107.
39. Wang, A.H., Bertos, N.R., Vezmar, M., Pelletier, N., Crosato, M., Heng, H.H., Th'ng, J., Han, J. and Yang, X.L. (1999) HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol., 19, 7816-7827.
40. Phillips, M.S., Fujii, J., Khanna, V.K., DeLeon, S., Yokobata, K., DeJong, P. and MacLennan, D.H. (1996) The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics, 34, 24-41.
41. Won, J., Yim, J. and Kim, T.K. (2002) Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J. Biol. Chem., 277, 38230-38238.
42. Zhou, H., Brockington, M., Jungbluth, H., Monk, D., Stanier, P., Sewry, C.A., Moore, G.E. and Muntoni, F. (2006) Epigenetic allele silencing unveils recessive RYR1 mutations in coremyopathies. Am. J. Hum. Gen., 79, 859-868.
43. Denis, H., Ndlovu, M.N. and Fuks, F. (2011) Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Reports, 12, 647-656.
44. Subramaniam, D., Thombre, R.T., Dhar, A. and Anant, S. (2014) DNA methyltransferases: a novel target for prevention and therapy. Front. Oncol., 4. doi:10.3389/fonc.2014.00080.
45. Newell-Price, J., Clark, A.J. and King, P. (2000) DNA methylation and silencing of gene expression. Trends. Endocrinol. Metab., 11, 142-148.
46. Cuozzo, C., Porcellini, A., Angrisano, T., Morano, A., Lee, B., Di Pardo, A., Messina, S., Iuliano, R., Fusco, A., Santillo, M.R. et al. (2007) DNA damage, homology-directed repair, and DNA methylation. PLOS Genet, 3, e110.
47. Huang, Z.P., Chen, J., Seok, H.Y., Zhang, Z., Kataoka, M., Hu, X. and Wang, D.Z. (2013) MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res., 112, 1234-1243.
48. Eisenberg, I., Eran, A., Nishinom, I., Moggio, M., Lamperti, C., Amatom, A.A., Lidov, H.G., Kang, P.B., North, K.N., Mitrani-Rosenbaum, S. et al. (2007) Distinctive patterns of microRNA expression in primary muscle disorders. Proc. Natl Acad. Sci. USA, 104, 17016-17021.
49. Dmitriev, P., Stankevicins, L., Ansseau, E., Petrov, A., Barat, A., Dessen, P., Robert, T., Turki, A., Lazar, V., Labourer, E. et al. (2013) Defective regulation of microRNA target genes in myoblasts from fascioscapulohumeral dystrophy patients. J. Biol. Chem., 288, 34989-35002.
50. Chen, J.F., Callis, T.E. and Wang, D.Z. (2009) microRNAs and muscle disorders. J. Cell Sci., 122, 13-20.
51. Liu, N., Bezprozvannaya, S., Shelton, J.M., Frisard, M.I., Hulver, M.W., McMillan, R.P., Wu, Y., Voelker, K.A., Grange, R.W., Richardson, J.A., Bassel-Duby, R. and Olson, E.N. (2011) Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J. Clin. Invest., 121, 3258-3268.
52. Vosin, S., Eynon, N., Yan, X. and Bishop, D.J. (2014) Exercise training and DNA methylation in humans. Acta. Physiol., doi:10.1111/apha.12414.
53. Ling, C. and Rönn, T. (2014) Epigenetic adaptation to regular exercise in humans. Drug Discov. Today, 19, 1015-1018.
54. Barrès, R., Yan, J., Egan, B., Treebak, J.T., Rasmussen, M., Fritz, T., Caidahl, K., Krook, A., O'Gorman, D.J. and Zierath, J.R. (2012) Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metabol., 15, 405-411.
55. Lee, W.H., Isaacs, W.B., Bova, G.S. and Nelson, W.G. (1997) CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol. Biomarkers Prev., 6, 443-450.
56. Obermann, W.M.J., Gautel, M., Steiner, F., van der Ven, P.F., Weber, K. and Fürst, D.O. (1996) The structure of the sarcomericMband: localization of defined domains of myomesin, M-protein and the 250 kD carboxy-terminal region of titin by immunoelectron microscopy. J. Cell Biol., 134, 1441-1453.
57. DiFranco, M., Quinonez, M., Capote, J. and Vergara, J. (2009) DNA transfection of mammalian skeletal muscles using in vivo electroporation. J. Vis. Exp., pii: 1520. doi:10.3791/1520.
58. Ducreux, S., Zorzato, F., Müller, C., Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T. and Treves, S. (2004) Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol. Chem., 279, 43838-43846.